PFIZER
Quarterly Results Analysis [Jun2025]
PFIZER Quarterly Results
| Standalone | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹603 Cr | ₹592 Cr | ₹538 Cr | ₹589 Cr | ₹563 Cr | ₹547 Cr | ₹540 Cr | ₹575 Cr |
| Expenses | ₹393 Cr | ₹364 Cr | ₹392 Cr | ₹399 Cr | ₹385 Cr | ₹357 Cr | ₹387 Cr | ₹393 Cr |
| Operating Income | ₹210 Cr | ₹228 Cr | ₹146 Cr | ₹189 Cr | ₹177 Cr | ₹189 Cr | ₹153 Cr | ₹183 Cr |
| Other Income | ₹67 Cr | ₹45 Cr | ₹43 Cr | ₹43 Cr | ₹42 Cr | ₹75 Cr | ₹36 Cr | ₹36 Cr |
| Interest | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹7 Cr | ₹3 Cr | ₹3 Cr |
| Depreciation | ₹14 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹18 Cr | ₹15 Cr |
| Profit Before Tax | ₹260 Cr | ₹426 Cr | ₹172 Cr | ₹215 Cr | ₹203 Cr | ₹244 Cr | ₹176 Cr | ₹201 Cr |
| Profit After Tax | ₹192 Cr | ₹331 Cr | ₹128 Cr | ₹158 Cr | ₹151 Cr | ₹179 Cr | ₹130 Cr | ₹149 Cr |
| EPS | ₹41.91 | ₹72.34 | ₹27.89 | ₹34.61 | ₹32.94 | ₹39.10 | ₹28.41 | ₹32.56 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PFIZER | -2.8% | -2.1% | 1.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | 3.6% | -7.8% |
| DIVIS LABORATORIES | 4.4% | 15.9% | 15.6% |
| CIPLA | -4.9% | -0.8% | 6.6% |
| TORRENT PHARMACEUTICALS | -0.6% | 1.8% | 15.7% |
| DR REDDYS LABORATORIES | -4.1% | -3.8% | -4.3% |
| MANKIND PHARMA | -3.1% | -3.3% | -8.6% |
| ZYDUS LIFESCIENCES | -2.9% | -1.6% | -0.5% |
| LUPIN | 2.1% | 1.3% | -8% |
PFIZER Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 1.88 % |
| Y-o-Y | 7.14 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2025 | ₹603 Cr | 1.88 | |
| Mar2025 | ₹592 Cr | 10.02 | |
| Dec2024 | ₹538 Cr | -8.60 | |
| Sep2024 | ₹589 Cr | 4.57 | |
| Jun2024 | ₹563 Cr | 2.97 | |
| Mar2024 | ₹547 Cr | 1.23 | |
| Dec2023 | ₹540 Cr | -6.13 | |
| Sep2023 | ₹575 Cr | - | |
PFIZER Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -7.68 % |
| Y-o-Y | 18.33 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2025 | ₹210 Cr | -7.68 | |
| Mar2025 | ₹228 Cr | 55.83 | |
| Dec2024 | ₹146 Cr | -22.86 | |
| Sep2024 | ₹189 Cr | 6.63 | |
| Jun2024 | ₹177 Cr | -6.30 | |
| Mar2024 | ₹189 Cr | 24.18 | |
| Dec2023 | ₹153 Cr | -16.46 | |
| Sep2023 | ₹183 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -9.37 % |
| Y-o-Y | 10.47 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2025 | 34.83% | -9.37 | |
| Mar2025 | 38.43% | 41.60 | |
| Dec2024 | 27.14% | -15.58 | |
| Sep2024 | 32.15% | 1.97 | |
| Jun2024 | 31.53% | -9.00 | |
| Mar2024 | 34.65% | 22.65 | |
| Dec2023 | 28.25% | -11.02 | |
| Sep2023 | 31.75% | - | |
PFIZER Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -42.06 % |
| Y-o-Y | 27.23 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2025 | ₹192 Cr | -42.06 | |
| Mar2025 | ₹331 Cr | 159.36 | |
| Dec2024 | ₹128 Cr | -19.42 | |
| Sep2024 | ₹158 Cr | 5.07 | |
| Jun2024 | ₹151 Cr | -15.74 | |
| Mar2024 | ₹179 Cr | 37.61 | |
| Dec2023 | ₹130 Cr | -12.74 | |
| Sep2023 | ₹149 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -43.12 % |
| Y-o-Y | 18.75 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2025 | 31.8 % | -43.12 | |
| Mar2025 | 55.91 % | 135.71 | |
| Dec2024 | 23.72 % | -11.82 | |
| Sep2024 | 26.9 % | 0.45 | |
| Jun2024 | 26.78 % | -18.15 | |
| Mar2024 | 32.72 % | 35.94 | |
| Dec2023 | 24.07 % | -7.07 | |
| Sep2023 | 25.9 % | - | |
PFIZER Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -42.07 % |
| Y-o-Y | 27.23 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2025 | ₹41.91 | -42.07 | |
| Mar2025 | ₹72.34 | 159.38 | |
| Dec2024 | ₹27.89 | -19.42 | |
| Sep2024 | ₹34.61 | 5.07 | |
| Jun2024 | ₹32.94 | -15.75 | |
| Mar2024 | ₹39.1 | 37.63 | |
| Dec2023 | ₹28.41 | -12.75 | |
| Sep2023 | ₹32.56 | - | |
You may also like the below Video Courses